H. Kluter et al., DEFECTIVE PRODUCTION OF INTERLEUKIN-2 IN PATIENTS WITH IDIOPATHIC PARKINSONS-DISEASE, Journal of the neurological sciences, 133(1-2), 1995, pp. 134-139
The pathogenesis of Parkinson's disease (PD) is largely unknown. Recen
tly, several studies have presented evidence of an immunological dysfu
nction in patients suffering from PD. We studied the immune responsive
ness of patients with idiopathic PD (n = 20) by investigation of the a
bility of peripheral blood mononuclear cells to produce cytokines afte
r mitogenic stimulation in a whole blood assay. A group of age-related
healthy blood donors served as control (n = 19). Additionally, white
blood count, leukocyte differentiation and lymphocyte subtyping were p
erformed. PD patients had a significantly higher neutrophil count, but
analysis of T-cell subsets showed no difference between the two group
s. In peripheral blood, secretion of interleukin-2 (IL-2) after mitoge
nic stimulation was significantly diminished in the patients' group (p
< 0.01), whereas values of IFN-alpha 2, IL-6, IFN-gamma and sIL-2R we
re comparable in both groups. IL-2 production correlated negatively wi
th the mean annual dose of levodopa treatment and correlated significa
ntly (p < 0.002) with amantadine uptake. Analysis of sex, age, duratio
n of illness and other drug intake revealed no correlation with cytoki
ne release. Out findings support the view that there is a selective ab
normality in the immune repertoire of peripheral blood lymphocytes in
patients suffering from PD, the reasons for which need to be explored.